A detailed history of Los Angeles Capital Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 468,385 shares of LLY stock, worth $365 Million. This represents 1.68% of its overall portfolio holdings.

Number of Shares
468,385
Previous 463,995 0.95%
Holding current value
$365 Million
Previous $420 Million 1.22%
% of portfolio
1.68%
Previous 1.5%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$772.14 - $960.02 $3.39 Million - $4.21 Million
4,390 Added 0.95%
468,385 $415 Million
Q2 2024

Aug 05, 2024

BUY
$724.87 - $909.04 $12.3 Million - $15.5 Million
17,001 Added 3.8%
463,995 $420 Million
Q1 2024

Apr 05, 2024

BUY
$592.2 - $792.28 $7.96 Million - $10.7 Million
13,446 Added 3.1%
446,994 $348 Million
Q4 2023

Feb 06, 2024

SELL
$525.19 - $619.13 $99 Million - $117 Million
-188,462 Reduced 30.3%
433,548 $253 Million
Q3 2023

Nov 06, 2023

BUY
$434.7 - $599.3 $89.4 Million - $123 Million
205,704 Added 49.41%
622,010 $334 Million
Q2 2023

Aug 03, 2023

BUY
$350.74 - $468.98 $20.3 Million - $27.2 Million
57,928 Added 16.16%
416,306 $195 Million
Q1 2023

May 04, 2023

BUY
$310.63 - $364.82 $82.6 Million - $97 Million
265,916 Added 287.59%
358,378 $123 Million
Q4 2022

Feb 06, 2023

SELL
$321.55 - $374.67 $36.7 Million - $42.7 Million
-114,034 Reduced 55.22%
92,462 $33.8 Million
Q3 2022

Nov 02, 2022

SELL
$296.48 - $337.87 $81.8 Million - $93.2 Million
-275,816 Reduced 57.19%
206,496 $66.8 Million
Q2 2022

Aug 05, 2022

BUY
$278.73 - $327.27 $49.2 Million - $57.7 Million
176,351 Added 57.64%
482,312 $156 Million
Q1 2022

May 06, 2022

BUY
$234.69 - $291.66 $42.7 Million - $53.1 Million
182,038 Added 146.9%
305,961 $87.6 Million
Q4 2021

Feb 03, 2022

BUY
$224.85 - $279.04 $7.13 Million - $8.85 Million
31,705 Added 34.38%
123,923 $34.2 Million
Q3 2021

Nov 08, 2021

SELL
$221.6 - $272.71 $22,824 - $28,089
-103 Reduced 0.11%
92,218 $21.3 Million
Q2 2021

Aug 05, 2021

SELL
$180.55 - $233.54 $44.4 Million - $57.5 Million
-246,129 Reduced 72.72%
92,321 $21.2 Million
Q1 2021

May 05, 2021

SELL
$164.32 - $212.72 $355,259 - $459,900
-2,162 Reduced 0.63%
338,450 $63.2 Million
Q4 2020

Feb 04, 2021

SELL
$130.46 - $172.63 $3.5 Million - $4.64 Million
-26,860 Reduced 7.31%
340,612 $57.5 Million
Q3 2020

Nov 02, 2020

SELL
$146.22 - $169.13 $39.7 Million - $45.9 Million
-271,536 Reduced 42.49%
367,472 $54.4 Million
Q2 2020

Aug 05, 2020

SELL
$136.42 - $164.18 $14 Million - $16.9 Million
-102,812 Reduced 13.86%
639,008 $105 Million
Q1 2020

May 04, 2020

BUY
$119.05 - $147.35 $5.38 Million - $6.66 Million
45,173 Added 6.48%
741,820 $103 Million
Q4 2019

Feb 07, 2020

BUY
$106.92 - $132.43 $2.82 Million - $3.49 Million
26,352 Added 3.93%
696,647 $91.6 Million
Q3 2019

Nov 07, 2019

BUY
$106.79 - $116.16 $36.6 Million - $39.8 Million
342,832 Added 104.69%
670,295 $75 Million
Q2 2019

Jul 29, 2019

SELL
$110.79 - $129.32 $1.73 Million - $2.02 Million
-15,648 Reduced 4.56%
327,463 $36.3 Million
Q1 2019

Apr 25, 2019

SELL
$111.31 - $131.02 $22.8 Million - $26.8 Million
-204,632 Reduced 37.36%
343,111 $44.5 Million
Q4 2018

Feb 11, 2019

BUY
$105.9 - $118.64 $1.45 Million - $1.62 Million
13,686 Added 2.56%
547,743 $63.4 Million
Q3 2018

Nov 05, 2018

SELL
$85.86 - $107.31 $150,255 - $187,792
-1,750 Reduced 0.33%
534,057 $57.3 Million
Q2 2018

Jul 31, 2018

BUY
$75.7 - $86.88 $6.13 Million - $7.04 Million
81,011 Added 17.81%
535,807 $45.7 Million
Q1 2018

Apr 27, 2018

SELL
$74.21 - $87.6 $7.01 Million - $8.28 Million
-94,470 Reduced 17.2%
454,796 $35.2 Million
Q4 2017

Feb 05, 2018

SELL
$81.94 - $87.89 $983,198 - $1.05 Million
-11,999 Reduced 2.14%
549,266 $46.4 Million
Q3 2017

Nov 06, 2017

BUY
$77.07 - $85.54 $2.66 Million - $2.96 Million
34,564 Added 6.56%
561,265 $48 Million
Q2 2017

Aug 09, 2017

BUY
N/A
526,701
526,701 $43.3 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.